Stratification of chronic kidney disease (CKD) patients at risk for progressing to kidney failure requiring kidney replacement therapy (KFRT) is important for clinical decision-making and trial enrollment. Four independent prospective observational cohort studies. The development cohort comprised 4,915 CKD patients, and 3 independent validation cohorts comprised a total of 3,063. Patients were observed for approximately 5 years. 22 demographic, anthropometric, and laboratory variables commonly assessed in CKD patients. Progression to KFRT. A least absolute shrinkage and selection operator (LASSO) Cox proportional hazards model was fit to select laboratory variables that best identified patients at high risk for KFRT. Model discrimination an...
ImportanceEarly identification of individuals at elevated risk of developing chronic kidney disease ...
BACKGROUND: Registry-based studies have identified risk factors for chronic kidney disease (CKD)...
Background: Validated prediction scores are required to assess the risks of end-stage renal disease ...
International audienceStratification of chronic kidney disease (CKD) patients at risk for progressin...
RATIONALE & OBJECTIVE: Stratification of chronic kidney disease (CKD) patients at risk for progr...
Rationale & Objective Stratification of chronic kidney disease (CKD) patients at risk for progressi...
BACKGROUND: Patients with chronic kidney disease (CKD) are at risk for progression to kidney failure...
Predicting the risk of end-stage renal disease (ESRD) progression facilitates appropriate nephrology...
Importance: Early identification of individuals at elevated risk of developing chronic kidney diseas...
RATIONALE AND OBJECTIVE The Kidney Failure Risk Equation (KFRE) predicts the risk of end-stage ki...
Importance: Early identification of individuals at elevated risk of developing chronic kidney diseas...
The discussion of chronic kidney disease (CKD), kidney replacement therapy (KRT), and end-stage kidn...
Introduction The externally validated Kidney Failure Risk Equation (KFRE) for predicting risk of ...
INTRODUCTION Chronic kidney disease (CKD) management in the UK is usually primary care based, wit...
PurposeWe aimed to develop a model of chronic kidney disease (CKD) progression for predicting the pr...
ImportanceEarly identification of individuals at elevated risk of developing chronic kidney disease ...
BACKGROUND: Registry-based studies have identified risk factors for chronic kidney disease (CKD)...
Background: Validated prediction scores are required to assess the risks of end-stage renal disease ...
International audienceStratification of chronic kidney disease (CKD) patients at risk for progressin...
RATIONALE & OBJECTIVE: Stratification of chronic kidney disease (CKD) patients at risk for progr...
Rationale & Objective Stratification of chronic kidney disease (CKD) patients at risk for progressi...
BACKGROUND: Patients with chronic kidney disease (CKD) are at risk for progression to kidney failure...
Predicting the risk of end-stage renal disease (ESRD) progression facilitates appropriate nephrology...
Importance: Early identification of individuals at elevated risk of developing chronic kidney diseas...
RATIONALE AND OBJECTIVE The Kidney Failure Risk Equation (KFRE) predicts the risk of end-stage ki...
Importance: Early identification of individuals at elevated risk of developing chronic kidney diseas...
The discussion of chronic kidney disease (CKD), kidney replacement therapy (KRT), and end-stage kidn...
Introduction The externally validated Kidney Failure Risk Equation (KFRE) for predicting risk of ...
INTRODUCTION Chronic kidney disease (CKD) management in the UK is usually primary care based, wit...
PurposeWe aimed to develop a model of chronic kidney disease (CKD) progression for predicting the pr...
ImportanceEarly identification of individuals at elevated risk of developing chronic kidney disease ...
BACKGROUND: Registry-based studies have identified risk factors for chronic kidney disease (CKD)...
Background: Validated prediction scores are required to assess the risks of end-stage renal disease ...